| Tag | Content |
|---|
EnhancerAtlas ID | HS139-09102 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr11:34095730-34097780 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GATA2 | MA0036.3 | chr11:34096055-34096066 | TTCTTATCTTC | + | 6.02 | | KLF4 | MA0039.3 | chr11:34096148-34096159 | GCAGGGTGTGG | - | 6.62 | | STAT1 | MA0137.3 | chr11:34096995-34097006 | TTTCCAGGAAA | + | 6.62 | | Stat4 | MA0518.1 | chr11:34096995-34097009 | TTTCCAGGAAAGAA | + | 6.38 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_11721 | chr11:34095246-34096984 | CD20 | | SE_13723 | chr11:34096587-34097302 | CD34_Primary_RO01536 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr11 | 34096626 | 34096900 | | chr11 | 34096936 | 34097299 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I034074 | chr11 | 34096149 | 34097736 |
|
Enhancer Sequence | AATTTCTTTT TCTTGCTTTT TTAAAATAGA AGCAGGATTG CTATACAGTT TAATGTAACA 60
TCTATTTTGG AAGTTACTAT CACTGTGTAA TGAAAATACC TGTATCCTTT TTTGCTTCTC 120
TTGTAACACT GGTATTTTCA GGACCTTTCT CTGAGCTTTA ACTTCATTAG CAGAGCTGTT 180
ATTTATCTTT GATCCTTTGG TATACTGTAC ACAATTATTA AACATGCTTT TTGTTTAGCA 240
TTCAAGAACT TCTTTAGCCT GGCTCCAGCC TACCTTTTCA CCTTTTTCCT TCTTGAACTG 300
TTCATTTCAT ACAGAATAGC TTTCTTTCTT ATCTTCTTTT GCTTTGTTAA CTTCCTTTCA 360
TATTCCTGTC CCTCTTCCTG TGTTTCCTGC CTCCACCTAC CTATAAAGAC CTTCCTGGGC 420
AGGGTGTGGT TGCTCACGCC TGTAACCCCA GCACTTTGGA AGGCCGAGGT GGGTGGATCA 480
CCTGAGGTCA GAAGTTCGAG ACCAGCCTGG CCAACATAGT GAAACCCTGT CTCTGCTAAA 540
AATACAAAAA TTAGCCGGGC TTGGCAGCAC ACACCTGTAA TCCCAGGAGG CTGAGGCAGC 600
AGAATTACTT GAATTCGAGA AGTAGAGGTG TCAGTGAGCC AAGATCGTGC CACTGCACTC 660
CTGGGCAACA GAGTGAGACT CCATCTCAAA AAACAAACAA AAAACACCTT CCTGGCTGGT 720
CATGGTGGCT CATACCTGTA ATCCTAGTAT TTTAAGGAGG CTGAGGTGAG AGGATCGCTT 780
GAGGCCAGGA GTTCAAGACC CAAGACCAGC CTTGGAAACA TAGACCTTGC CTCAAAAAAC 840
TTTTTTTAAA TTATTTTTTT AAAAAAGACT TTTTTTTTTT TCTTGAGACA GTCTCACTGT 900
TTCACCCAGG CTGGAGTGCA GTAGCATGAT CTCAGCTCAC TGTAGCTATC ACTTGCCATT 960
TATTGCTAAG ATATTTATTC TGCACACTCT GTTACCATTA TAGATTTGTC TTGTTCTTGC 1020
AGCCTTCATC ATTCTTCCCA GGTCTCCTTC CCCATTTTTC CCTTTAGTAT AGGTTTCATA 1080
TGTCCCTATT TTGGTTTTCT GTGTCTTGGT TCATCCTAGT GAGGCTTGAG AAGGGGGAAA 1140
AGGTGGAAAG GAAAGCACTA CCATGGCTTT TGAGAAGACT AGCCTTCCTC TATTCCCAAC 1200
CTCATGTTAG ATACACGGGA GAGGGAGAGG AATAATTGAG TTTGGCTGAT GCTTTCCTTT 1260
CAGCCTTTCC AGGAAAGAAA AAAAGGAATG TGGGAAAAAT ACATTCATAC TTAGCTTTAT 1320
CTATTTTTCT CCACCAGCAT CATCTTATTC ATAAAAACAA ATTAGGCACT CTTTTCAGTA 1380
AGATGGAATA ACTTTCTGAG ACTGGCAGCG GATTATTTGG GACAAAGGGG CCCTTGTGGG 1440
TTTTTGGCAT TTCCTTGTGA GTCATTAGTA GATACTCAAA GTTAGAACTT TGGGTCATTT 1500
GCCCATAGAG GAGCTAGATT GAGGTAAGAT TTTTATTGTT GCTGTGGTTG GGTTTCTTTT 1560
TTAATTGGCC TAGGCCTTTA CATTTCTGTA TAATTTCTAA ATTCATTAAA TTTTTACTTT 1620
TTATATGCAT AATGAAAAAC TTCAGATATA TATACCTAAC TAAAGAAAAC AATACAATGA 1680
AACTCTTTGT ACCTGTACCC AGCTTGTATA TTTATCATCT CATGGTCAAT CGTATTTCAT 1740
ATAAATCCAC ATTCATTTCC TTGCTCCCTT TGCCCTCTAG ATTATTTTCA AACAAGCCCC 1800
AAACACATTG TTTCATCAGT AATAGTTCAG TAGTAAAATA CCTTCTAGGG AAAGAGCTGT 1860
TCTGAATTTT TAACAATTGC TTAAAATAGA TTATGTTTAA AACTATTTGT AAGTCAGGAA 1920
TCATCCTTTT GTGTATTGAG GTCATATCTC ACTCATTGAG TAAAACATGT TTTATTTAAG 1980
CTGGACCTGA AATGGATTGA ACTAAGTTTT ATATAACTAA TTTTGGTGTT TTACTTTTAT 2040
ATTGTTTTGC 2050
|
